Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Beijing Huahao Zhongtian Biopharmaceutical

Request full access

Innovative oncology treatments targeting breast cancer brain metastasis with advanced pharmaceutical R&D

Dongcheng District, ChinaFounded 2002Biotech & Life Sciences

About Beijing Huahao Zhongtian Biopharmaceutical

Biostar Pharma is a biopharmaceutical company specializing in the development of innovative oncology treatments, particularly for breast cancer brain metastasis. The company operates in the pharmaceutical industry, focusing on research and development (R&D) to create advanced therapeutic solutions. Biostar Pharma's core product, Utidelone Injection UTD1, has received FDA clearance for a Phase 2 study and has shown promising results, including a 73% CNS ORR (Central Nervous System Overall Response Rate) and a 100% CBR (Clinical Benefit Rate). The company serves healthcare providers, hospitals, and clinics that treat cancer patients, particularly those with complex metastatic conditions. Biostar Pharma's business model revolves around the development, clinical testing, and eventual commercialization of its pharmaceutical products. Revenue is generated through the sale of these specialized treatments, as well as potential partnerships and licensing agreements with other pharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
4
Open positions
1
Dealroom signal
66.9/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Oct 2024 $24M $705M Undisclosed ↗
SERIES EOther financing Nov 2020 $135M $540M CCB International · Tianjin Venture Capital · Chengdu Bio-Town Investment · Matrix Partners China —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Beijing Huahao Zhongtian Biopharmaceutical website traffic

Latest recorded traffic for Beijing Huahao Zhongtian Biopharmaceutical is 350 monthly website visits, down 75% over the last three months. Beijing Huahao Zhongtian Biopharmaceutical's team grew 0% over the past year.

Latest monthly visits350 3-month web change-75% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Beijing Huahao Zhongtian Biopharmaceutical in the Dongcheng District ecosystem

Live from Dealroom

The Beijing Huahao Zhongtian Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later7 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Beijing Huahao Zhongtian Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Beijing Huahao Zhongtian Biopharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.